Researchers are excited about this new drug, a novel dual agonist showing significant results in early trials for weight loss . It functions by targeting both pathways : GLP-1 and GIP, that , when https://andrewotiz465429.free-blogz.com/88311142/this-new-possibility-for-weight-management